Form 4: Pfizer CEO Albert Bourla Acquires Phantom Stock Units Through Savings Plan

Pfizer's CEO, Albert Bourla, acquired 20 phantom stock units through the company's Supplemental Savings Plan.

Summary

• Pfizer CEO Albert Bourla acquired 20 phantom stock units on November 29, 2024, through the company's Supplemental Savings Plan.
• These units represent the equivalent of 20 shares of Pfizer common stock.
• The units will be settled in cash following Mr. Bourla's separation from service, but can be transferred to an alternative investment account at any time.
• Following this transaction, Mr. Bourla directly owns 690,388 shares of Pfizer common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally neutral to positive. The acquisition of phantom stock units aligns the CEO's interests with the company's performance.

Positives

• The acquisition of phantom stock units through the savings plan aligns the CEO's interests with the company's performance.
• The ability to transfer the units to an alternative investment account provides flexibility for the CEO.

Industry Context

This is a routine filing related to executive compensation and is common practice for publicly traded companies. It reflects the ongoing management of executive compensation packages.

Comparison to Industry Standards

• The use of phantom stock units as part of executive compensation is a common practice among large publicly traded companies, including pharmaceutical companies like Johnson & Johnson and Merck.
• These plans are designed to align executive interests with shareholder value and are often part of a broader compensation strategy that includes salary, bonuses, and stock options.
• The specific terms of the Pfizer Supplemental Savings Plan, such as the cash settlement upon separation and the ability to transfer to an alternative investment account, are typical features of such plans.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with the company's performance.

Key Dates

Keywords

Pfizer, Albert Bourla, phantom stock units, Supplemental Savings Plan, executive compensation, insider trading, SEC Form 4